FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

TSANYANG LIANG

Research Profile

Living Beings

Disorders

Chemicals & Drugs

Anatomy

Physiology

Concepts & Ideas

Molecular Sequence Data

Co-author Network

Publications

TOP 3
Golo Ahlenstiel; Birgit Edlich; Jordan J Feld; Leah J Hogdal; Lauren E Holz; TSANYANG LIANG; Mazen Noureddin; Yaron Rotman; Rachel H Titerence; Barbara Rehermann
Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C.
Netanya G Sandler; Rebecca B Siegel; Steven G Deeks; Mary Demino; Jason L Eccleston; Theo Heller; David E Kleiner; Christopher Koh; TSANYANG LIANG; Annelys Roque; Daniel C Douek
Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection.
Heidi Barth; Thomas F Baumert; Youkyung Choi; Krzysztof Krawczynski; Romuald Patient; Jolanta Rybczynska; Ronda K Sapp; TSANYANG LIANG
Both innate and adaptive immunity mediate protective immunity against hepatitis C virus infection in chimpanzees.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of TSANYANG LIANG (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Golo Ahlenstiel; Birgit Edlich; Jordan J Feld; Leah J Hogdal; Lauren E Holz; TSANYANG LIANG; Mazen Noureddin; Yaron Rotman; Rachel H Titerence; Barbara Rehermann
Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C.
Gastroenterology 2011;141(4):1231-9, 1239.e1-2.
2011: Netanya G Sandler; Rebecca B Siegel; Steven G Deeks; Mary Demino; Jason L Eccleston; Theo Heller; David E Kleiner; Christopher Koh; TSANYANG LIANG; Annelys Roque; Daniel C Douek
Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection.
Gastroenterology 2011;141(4):1220-30, 1230.e1-3.
2011: Heidi Barth; Thomas F Baumert; Youkyung Choi; Krzysztof Krawczynski; Romuald Patient; Jolanta Rybczynska; Ronda K Sapp; TSANYANG LIANG
Both innate and adaptive immunity mediate protective immunity against hepatitis C virus infection in chimpanzees.
Hepatology (Baltimore, Md.) 2011;54(4):1135-48.
2011: R Loomba; M M Rivera; R McBurney; Y Park; V Haynes-Williams; B Rehermann; Harvey Alter; Steven K Herrine; TSANYANG LIANG; Jay H Hoofnagle; Theo Heller
The natural history of acute hepatitis C: clinical presentation, laboratory findings and treatment outcomes.
Alimentary pharmacology & therapeutics 2011;33(5):559-65.
2011: Jordan J Feld; Apurva A Modi; Ramy El-Diwany; Yaron Rotman; Emmanuel Thomas; Golo Ahlenstiel; Rachel Titerence; Christopher Koh; Vera Cherepanov; Theo Heller; Marc G Ghany; Yoon Park; Jay H Hoofnagle; TSANYANG LIANG
S-adenosyl methionine improves early viral responses and interferon-stimulated gene induction in hepatitis C nonresponders.
Gastroenterology 2011;140(3):830-9.
2011: Naga Suresh Veerapu; Sukanya Raghuraman; TSANYANG LIANG; Theo Heller; Barbara Rehermann
Sporadic reappearance of minute amounts of hepatitis C virus RNA after successful therapy stimulates cellular immune responses.
Gastroenterology 2011;140(2):676-685.e1.
2011: Emmanuel Thomas; Jordan J Feld; Qisheng Li; Zongyi Hu; Michael W Fried; TSANYANG LIANG
Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture models.
Hepatology (Baltimore, Md.) 2011;53(1):32-41.
2010: Yaron Rotman; Christopher Koh; Joseph Zmuda; David E Kleiner; TSANYANG LIANG
The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease.
Hepatology (Baltimore, Md.) 2010;52(3):894-903.
2010: Zhensheng Zhang; Eun Sun; Jing-hsiung James Ou; TSANYANG LIANG
Inhibition of cellular proteasome activities mediates HBX-independent hepatitis B virus replication in vivo.
Journal of virology 2010;84(18):9326-31.
2010: Nabora Soledad Reyes de Mochel; Scott Seronello; Shelley Hsiuying Wang; Chieri Ito; Jasper Xi Zheng; TSANYANG LIANG; J David Lambeth; Jinah Choi
Hepatocyte NAD(P)H oxidases as an endogenous source of reactive oxygen species during hepatitis C virus infection.
Hepatology (Baltimore, Md.) 2010;52(1):47-59.
2010: Jordan J Feld; Glen A Lutchman; Theo Heller; Koji Hara; Julie K Pfeiffer; Richard D Leff; Claudia Meek; Maria Rivera; Myung Ko; Christopher Koh; Yaron Rotman; Marc G Ghany; Vanessa Haynes-Williams; Avidan U Neumann; TSANYANG LIANG; Jay H Hoofnagle
Ribavirin improves early responses to peginterferon through improved interferon signaling.
Gastroenterology 2010;139(1):154-62.e4.
2010: Y Rotman; Brian Borg; Alejandro Soza; J J Feld; A A Modi; R Loomba; Glen Lutchman; E Rivera; Edward Doo; Marc G Ghany; Theo Heller; A U Neumann; TSANYANG LIANG; Jay H Hoofnagle
Low- and standard-dose peginterferon alfa-2a for chronic hepatitis C, genotype 2 or 3: efficacy, tolerability, viral kinetics and cytokine response.
Alimentary pharmacology & therapeutics 2010;31(9):1018-27.
2010: Xiaosong He; Santosh Nanda; Xuhuai Ji; Gloria M Calderon-Rodriguez; Harry B Greenberg; TSANYANG LIANG
Differential transcriptional responses to interferon-alpha and interferon-gamma in primary human hepatocytes.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2010;30(5):311-20.
2010: Marion G Peters; Cindy Weinbaum; Litjen Tan; William B Baine; Jules L Dienstag; TSANYANG LIANG; Samuel So
Recommendations for prevention, screening, and diagnosis of HBV and HCV infections.
The Journal of family practice 2010;59(4 Suppl):S29-35.
2010: Yong-Yuan Zhang; Bai-Hua Zhang; Koji Ishii; TSANYANG LIANG
Novel function of CD81 in controlling hepatitis C virus replication.
Journal of virology 2010;84(7):3396-407.
2010: Apurva A Modi; Jordan J Feld; Yoon Park; David E Kleiner; James E Everhart; TSANYANG LIANG; Jay H Hoofnagle
Increased caffeine consumption is associated with reduced hepatic fibrosis.
Hepatology (Baltimore, Md.) 2010;51(1):201-9.
2010: Golo Ahlenstiel; Rachel H Titerence; Christopher Koh; Birgit Edlich; Jordan J Feld; Yaron Rotman; Marc G Ghany; Jay H Hoofnagle; TSANYANG LIANG; Theo Heller; Barbara Rehermann
Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner.
Gastroenterology 2010;138(1):325-35.e1-2.
2009: Tara N Palmore; Neeral L Shah; Rohit Loomba; Brian B Borg; Uri Lopatin; Jordan J Feld; Farooq Khokhar; Glen Lutchman; David E Kleiner; Neal S Young; Richard Childs; A John Barrett; TSANYANG LIANG; Jay H Hoofnagle; Theo Heller
Reactivation of hepatitis B with reappearance of hepatitis B surface antigen after chemotherapy and immunosuppression.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2009;7(10):1130-7.
2009: Qisheng Li; Abraham L Brass; Aylwin Ng; Zongyi Hu; Ramnik J Xavier; TSANYANG LIANG; Stephen J Elledge
A genome-wide genetic screen for host factors required for hepatitis C virus propagation.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(38):16410-5.
2009: Yaron Rotman; TSANYANG LIANG
Coinfection with hepatitis C virus and human immunodeficiency virus: virological, immunological, and clinical outcomes.
Journal of virology 2009;83(15):7366-74.
2009: Takuya Matsumura; Zongyi Hu; Takanobu Kato; Marlene Dreux; Yong-Yuan Zhang; Michio Imamura; Nobuhiko Hiraga; Jean-Marc Juteau; Francois-Loic Cosset; Kazuaki Chayama; Andrew Vaillant; TSANYANG LIANG
Amphipathic DNA polymers inhibit hepatitis C virus infection by blocking viral entry.
Gastroenterology 2009;137(2):673-81.
2009: Theo Heller; Jay Hoofnagle; TSANYANG LIANG; Barbara Rehermann
Acute hepatitis C.
Gastroenterology 2009;136(7):2411.
2009: L J Yee; KyungAh Im; B Borg; Huiying Yang; TSANYANG LIANG
Interleukin-6 haplotypes and the response to therapy of chronic hepatitis C virus infection.
Genes and immunity 2009;10(4):365-72.
2009: TSANYANG LIANG
Hepatitis B: the virus and disease.
Hepatology (Baltimore, Md.) 2009;49(5 Suppl):S13-21.
2009: Leland J Yee; KyungAh Im; Abdus Wahed; Teodorica Bugawan; Jia Li; Shannon L Rhodes; Henry Erlich; Hugo R Rosen; TSANYANG LIANG; Huiying Yang
Polymorphism in the human major histocompatibility complex and early viral decline during treatment of chronic hepatitis C.
Antimicrobial agents and chemotherapy 2009;53(2):615-21.
2009: A Danielle Iuliano; Eleanor Feingold; Abdus Wahed; David E Kleiner; Steven H Belle; Hari S Conjeevaram; Joseph Zmuda; TSANYANG LIANG; Leland J Yee
Host genetics, steatosis and insulin resistance among African Americans and Caucasian Americans with hepatitis C virus genotype-1 infection.
Intervirology 2009;52(1):49-56.
2009: Christopher Koh; TSANYANG LIANG
Settling the "score" with liver cancer.
Journal of hepatology 2009;50(1):7-9.
2009: R Loomba; Glen Lutchman; David E Kleiner; M Ricks; Jordan J Feld; Brian Borg; A Modi; P Nagabhyru; A E Sumner; TSANYANG LIANG; Jay H Hoofnagle
Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis.
Alimentary pharmacology & therapeutics 2009;29(2):172-82.
2008: Rohit Loomba; Robert Wesley; Frank Pucino; TSANYANG LIANG; David E Kleiner; Joel Edward Lavine
Placebo in nonalcoholic steatohepatitis: insight into natural history and implications for future clinical trials.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2008;6(11):1243-8.
2008: Takanobu Kato; Youkyung Choi; Gamal Elmowalid; Ronda K Sapp; Heidi Barth; Akihiro Furusaka; Shunji Mishiro; Takaji Wakita; Krzysztof Krawczynski; TSANYANG LIANG
Hepatitis C virus JFH-1 strain infection in chimpanzees is associated with low pathogenicity and emergence of an adaptive mutation.
Hepatology (Baltimore, Md.) 2008;48(3):732-40.
2008: Xiaowen Su; Leland J Yee; KyungAh Im; Shannon L Rhodes; YongMing Tang; Xiaomei Tong; Charles D Howell; Darmendra Ramcharran; Hugo Rosen; Milton W Taylor; TSANYANG LIANG; Huiying Yang
Association of single nucleotide polymorphisms in interferon signaling pathway genes and interferon-stimulated genes with the response to interferon therapy for chronic hepatitis C.
Journal of hepatology 2008;49(2):184-91.
2008: Heidi Barth; Eric Robinet; TSANYANG LIANG; Thomas F Baumert
Mouse models for the study of HCV infection and virus-host interactions.
Journal of hepatology 2008;49(1):134-42.
2008: Rohit Loomba; Ayana K Rowley; Robert Wesley; karen smith; TSANYANG LIANG; Frank Pucino; Gyorgy Csako
Hepatitis B immunoglobulin and Lamivudine improve hepatitis B-related outcomes after liver transplantation: meta-analysis.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2008;6(6):696-700.
2008: Jordan J Feld; Nadeem Hussain; Elizabeth C Wright; David E Kleiner; Jay H Hoofnagle; Sushil K Ahlawat; Victoria Anderson; Dianne Hilligoss; John Gallin; TSANYANG LIANG; Harry L Malech; Steven M Holland; Theo Heller
Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease.
Gastroenterology 2008;134(7):1917-26.
2008: S L Rhodes; Henry A Erlich; K A Im; J Wang; J Li; T Bugawan; Lennox Jeffers; X Tong; X Su; Hugo Rosen; L J Yee; TSANYANG LIANG; H Yang
Associations between the human MHC and sustained virologic response in the treatment of chronic hepatitis C virus infection.
Genes and immunity 2008;9(4):328-33.
2008: Rohit Loomba; Shih-Jen Hwang; Christopher J O'Donnell; R Curtis Ellison; Ramachandran S Vasan; Ralph B D'Agostino; TSANYANG LIANG; Caroline S Fox
Parental obesity and offspring serum alanine and aspartate aminotransferase levels: the Framingham heart study.
Gastroenterology 2008;134(4):953-9.
2008: Rohit Loomba; Ayana Rowley; Robert Wesley; TSANYANG LIANG; Jay H Hoofnagle; Frank Pucino; Gyorgy Csako
Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy.
Annals of internal medicine 2008;148(7):519-28.
2008: Heidi Barth; Eva K Schnober; Christoph Neumann-Haefelin; Christine Thumann; Mirjam B Zeisel; Helmut M Diepolder; Zongyi Hu; TSANYANG LIANG; Hubert E Blum; Robert Thimme; Mélanie Lambotin; Thomas F Baumert
Scavenger receptor class B is required for hepatitis C virus uptake and cross-presentation by human dendritic cells.
Journal of virology 2008;82(7):3466-79.
2008: Jean-Michel Pawlotsky; Geoffrey Dusheiko; Angelos Hatzakis; Daryl Lau; George Lau; TSANYANG LIANG; Stephen Locarnini; Paul Martin; Douglas D Richman; Fabien Zoulim
Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach.
Gastroenterology 2008;134(2):405-15.
2008: Santosh Nanda; Michael B Havert; Gloria M Calderón; Michael Thomson; Christian Jacobson; Daniel Kastner; TSANYANG LIANG
Hepatic transcriptome analysis of hepatitis C virus infection in chimpanzees defines unique gene expression patterns associated with viral clearance.
PloS one 2008;3(10):e3442.
2008: A A Modi; TSANYANG LIANG
Hepatitis C: a clinical review.
Oral diseases 2008;14(1):10-4.
2008: Raymond T Chung; Michael Gale; Stephen Polyak; Stanley M Lemon; TSANYANG LIANG; Jay H Hoofnagle
Mechanisms of action of interferon and ribavirin in chronic hepatitis C: Summary of a workshop.
Hepatology (Baltimore, Md.) 2008;47(1):306-20.
2007: Jordan J Feld; Santosh Nanda; Ying Huang; Weiping Chen; Margaret C Cam; Susan N Pusek; Lisa M Schweigler; Dickens Theodore; Steven L Zacks; TSANYANG LIANG; Michael W Fried
Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response.
Hepatology (Baltimore, Md.) 2007;46(5):1548-63.
2007: Xuekui Yu; Ming Qiao; Ivo Atanasov; Zongyi Hu; Takanobu Kato; TSANYANG LIANG; Z Hong Zhou
Cryo-electron microscopy and three-dimensional reconstructions of hepatitis C virus particles.
Virology 2007;367(1):126-34.
2007: Satoru Saito; Theo Heller; Masashi Yoneda; Hirokazu Takahashi; Atsushi Nakajima; TSANYANG LIANG
Lifestyle-related diseases of the digestive system: a new in vitro model of hepatitis C virion production: application of basic research on hepatitis C virus to clinical medicine.
Journal of pharmacological sciences 2007;105(2):138-44.
2007: Glen Lutchman; Apurva Modi; David E Kleiner; Kittichai Promrat; Theo Heller; Marc G Ghany; Brian Borg; Rohit Loomba; TSANYANG LIANG; Ahalya Premkumar; Jay H Hoofnagle
The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis.
Hepatology (Baltimore, Md.) 2007;46(2):424-9.
2007: TSANYANG LIANG
Shortened therapy for hepatitis C virus genotype 2 or 3--is less more?
The New England journal of medicine 2007;357(2):176-8.
2007: Leland J Yee; Yong-Ming Tang; David E Kleiner; Dai Wang; KyungAh Im; Abdus Wahed; Xiaomei Tong; Shannon Rhodes; Xiaowen Su; R Margaret Whelan; Robert J Fontana; Marc G Ghany; Brian Borg; TSANYANG LIANG; Huiying Yang
Myxovirus-1 and protein kinase haplotypes and fibrosis in chronic hepatitis C virus.
Hepatology (Baltimore, Md.) 2007;46(1):74-83.
2007: Gamal A Elmowalid; Ming Qiao; Sook-Hyang Jeong; Brian B Borg; Thomas F Baumert; Ronda K Sapp; Zongyi Hu; Krishna K Murthy; TSANYANG LIANG
Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(20):8427-32.
2007: Glen Lutchman; Susan Danehower; Byung-Cheol Song; TSANYANG LIANG; Jay H Hoofnagle; Michael Thomson; Marc G Ghany
Mutation rate of the hepatitis C virus NS5B in patients undergoing treatment with ribavirin monotherapy.
Gastroenterology 2007;132(5):1757-66.
2007: Takanobu Kato; Takuya Matsumura; Theo Heller; Satoru Saito; Ronda K Sapp; Krishna K Murthy; Takaji Wakita; TSANYANG LIANG
Production of infectious hepatitis C virus of various genotypes in cell cultures.
Journal of virology 2007;81(9):4405-11.
2007: Marc G Ghany; TSANYANG LIANG
Drug targets and molecular mechanisms of drug resistance in chronic hepatitis B.
Gastroenterology 2007;132(4):1574-85.
2007: Jay H Hoofnagle; Edward Doo; TSANYANG LIANG; Russell Fleischer; Anna S F Lok
Management of hepatitis B: summary of a clinical research workshop.
Hepatology (Baltimore, Md.) 2007;45(4):1056-75.
2007: Nadeem Hussain; Jordan J Feld; David E Kleiner; Jay H Hoofnagle; Reyes Garcia-Eulate; Sushil K Ahlawat; Deloris E Koziel; Victoria Anderson; Dianne Hilligoss; Peter Choyke; John Gallin; TSANYANG LIANG; Harry L Malech; Steven M Holland; Theo Heller
Hepatic abnormalities in patients with chronic granulomatous disease.
Hepatology (Baltimore, Md.) 2007;45(3):675-83.
2007: Ying Huang; Jordan J Feld; Ronda K Sapp; Santosh Nanda; Jiing-Huey Lin; Lawrence M Blatt; Michael W Fried; Krishna K Murthy; TSANYANG LIANG
Defective hepatic response to interferon and activation of suppressor of cytokine signaling 3 in chronic hepatitis C.
Gastroenterology 2007;132(2):733-44.
2007: Ying Huang; Huiying Yang; Brian B Borg; Xiaowen Su; Shannon L Rhodes; Kai Yang; Xiaomei Tong; George Tang; Charles D Howell; Hugo Rosen; Chloe L Thio; David L Thomas; Harvey Alter; Ronda K Sapp; TSANYANG LIANG
A functional SNP of interferon-gamma gene is important for interferon-alpha-induced and spontaneous recovery from hepatitis C virus infection.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(3):985-90.
2007: Rohit Loomba; TSANYANG LIANG
Treatment of chronic hepatitis B.
Antiviral therapy 2007;12 Suppl 3():H33-41.
2006: Heidi Barth; TSANYANG LIANG; Thomas F Baumert
Hepatitis C virus entry: molecular biology and clinical implications.
Hepatology (Baltimore, Md.) 2006;44(3):527-35.
2006: Glen Lutchman; Kittichai Promrat; David E Kleiner; Theo Heller; Marc G Ghany; Jack A Yanovski; TSANYANG LIANG; Jay H Hoofnagle
Changes in serum adipokine levels during pioglitazone treatment for nonalcoholic steatohepatitis: relationship to histological improvement.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2006;4(8):1048-52.
2006: TSANYANG LIANG
Supporting the NIH before it is too late.
Hepatology (Baltimore, Md.) 2006;44(1):1-2.
2006: Ponni Perumalswami; David E Kleiner; Glen Lutchman; Theo Heller; Brian Borg; Yoon Park; TSANYANG LIANG; Jay H Hoofnagle; Marc G Ghany
Steatosis and progression of fibrosis in untreated patients with chronic hepatitis C infection.
Hepatology (Baltimore, Md.) 2006;43(4):780-7.
2006: Santosh Nanda; David Herion; TSANYANG LIANG
The SH3 binding motif of HCV [corrected] NS5A protein interacts with Bin1 and is important for apoptosis and infectivity.
Gastroenterology 2006;130(3):794-809.
2006: Jordan J Feld; TSANYANG LIANG
Hepatitis C -- identifying patients with progressive liver injury.
Hepatology (Baltimore, Md.) 2006;43(2 Suppl 1):S194-206.
2006: Zongyi Hu; Zhensheng Zhang; Jin Woo Kim; Ying Huang; TSANYANG LIANG
Altered proteolysis and global gene expression in hepatitis B virus X transgenic mouse liver.
Journal of virology 2006;80(3):1405-13.
2006: Rohit Loomba; TSANYANG LIANG
Novel approaches to new therapies for hepatitis B virus infection.
Antiviral therapy 2006;11(1):1-15.
2005: Anuradha Balasubramanian; Neru Munshi; Margaret James Koziel; Zongyi Hu; TSANYANG LIANG; Jerome E Groopman; Ramesh K Ganju
Structural proteins of Hepatitis C virus induce interleukin 8 production and apoptosis in human endothelial cells.
The Journal of general virology 2005;86(Pt 12):3291-301.
2005: Zhaohui Cai; Chen Zhang; Kyung-Soo Chang; Jieyun Jiang; Byung-Chul Ahn; Takaji Wakita; TSANYANG LIANG; Guangxiang Luo
Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells.
Journal of virology 2005;79(22):13963-73.
2005: Takaji Wakita; Thomas Pietschmann; Takanobu Kato; Tomoko Date; Michiko Miyamoto; Zijiang Zhao; Krishna K Murthy; Anja Habermann; Hans-Georg Kräusslich; Masashi Mizokami; Ralf Bartenschlager; TSANYANG LIANG
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome.
Nature medicine 2005;11(7):791-6.
2005: Heidi Barth; Axel Ulsenheimer; Gerd R Pape; Helmut M Diepolder; Marco Hoffmann; Christoph Neumann-Haefelin; Robert Thimme; Philipp Henneke; Reinhild Klein; Glaucia Paranhos-Baccalà; Erik Depla; TSANYANG LIANG; Hubert E Blum; Thomas F Baumert
Uptake and presentation of hepatitis C virus-like particles by human dendritic cells.
Blood 2005;105(9):3605-14.
2005: Theo Heller; Satoru Saito; Jonathan Auerbach; Tarice Williams; Tzivia Rachel Moreen; Allison Jazwinski; Brian Cruz; Neha Jeurkar; Ronda K Sapp; Guangxiang Luo; TSANYANG LIANG
An in vitro model of hepatitis C virion production.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(7):2579-83.
2005: Won Ho Kim; Feng Hong; Barbara Jaruga; Zheng Sheng Zhang; Sai-jun Fan; TSANYANG LIANG; Bin Gao
Hepatitis B virus X protein sensitizes primary mouse hepatocytes to ethanol- and TNF-alpha-induced apoptosis by a caspase-3-dependent mechanism.
Cellular & molecular immunology 2005;2(1):40-8.
2005: Thomas F Baumert; Chun Yang; Peter Schürmann; Josef Köck; Christian Ziegler; Carsten Grüllich; Michael Nassal; TSANYANG LIANG; Hubert E Blum; Fritz von Weizsäcker
Hepatitis B virus mutations associated with fulminant hepatitis induce apoptosis in primary Tupaia hepatocytes.
Hepatology (Baltimore, Md.) 2005;41(2):247-56.
2005: Jordan J Feld; TSANYANG LIANG
HCV persistence: cure is still a four letter word.
Hepatology (Baltimore, Md.) 2005;41(1):23-5.
2004: Ming Qiao; Mundrigi Ashok; Kristen A Bernard; Gustavo Palacios; Z Hong Zhou; W Ian Lipkin; TSANYANG LIANG
Induction of sterilizing immunity against West Nile Virus (WNV), by immunization with WNV-like particles produced in insect cells.
The Journal of infectious diseases 2004;190(12):2104-8.
2004: TSANYANG LIANG; Theo Heller
Pathogenesis of hepatitis C-associated hepatocellular carcinoma.
Gastroenterology 2004;127(5 Suppl 1):S62-71.
2004: Stephen Locarnini; Angelos Hatzakis; Jenny Heathcote; Emmet B Keeffe; TSANYANG LIANG; David Mutimer; Jean-Michel Pawlotsky; Fabien Zoulim
Management of antiviral resistance in patients with chronic hepatitis B.
Antiviral therapy 2004;9(5):679-93.
2004: Daniel Steinmann; Heidi Barth; Bettina Gissler; Peter Schürmann; Mohammed I Adah; J Tilman Gerlach; Gerd R Pape; Erik Depla; Dirk Jacobs; Geert Maertens; Arvind H Patel; Geneviève Inchauspé; TSANYANG LIANG; Hubert E Blum; Thomas F Baumert
Inhibition of hepatitis C virus-like particle binding to target cells by antiviral antibodies in acute and chronic hepatitis C.
Journal of virology 2004;78(17):9030-40.
2004: Fareed Rahman; Theo Heller; Yuji Sobao; Eishiro Mizukoshi; Michelina Nascimbeni; Harvey Alter; Steven Herrine; Jay H Hoofnagle; TSANYANG LIANG; Barbara Rehermann
Effects of antiviral therapy on the cellular immune response in acute hepatitis C.
Hepatology (Baltimore, Md.) 2004;40(1):87-97.
2004: Zhen-Yong Keck; Vicky M-H Sung; Susan Perkins; Judy Rowe; Sudhir Paul; TSANYANG LIANG; Michael M C Lai; Steven K H Foung
Human monoclonal antibody to hepatitis C virus E1 glycoprotein that blocks virus attachment and viral infectivity.
Journal of virology 2004;78(13):7257-63.
2004: Sook-Hyang Jeong; Ming Qiao; Michelina Nascimbeni; Zongyi Hu; Barbara Rehermann; Krishna K Murthy; TSANYANG LIANG
Immunization with hepatitis C virus-like particles induces humoral and cellular immune responses in nonhuman primates.
Journal of virology 2004;78(13):6995-7003.
2004: Zhensheng Zhang; Ulrike Protzer; Zongyi Hu; James Jacob; TSANYANG LIANG
Inhibition of cellular proteasome activities enhances hepadnavirus replication in an HBX-dependent manner.
Journal of virology 2004;78(9):4566-72.
2004: Zhaohui Cai; TSANYANG LIANG; Guangxiang Luo
Effects of mutations of the initiation nucleotides on hepatitis C virus RNA replication in the cell.
Journal of virology 2004;78(7):3633-43.
2004: Svetlana Radaeva; Barbara Jaruga; Won-Ho Kim; Theo Heller; TSANYANG LIANG; Bin Gao
Interferon-gamma inhibits interferon-alpha signalling in hepatic cells: evidence for the involvement of STAT1 induction and hyperexpression of STAT1 in chronic hepatitis C.
The Biochemical journal 2004;379(Pt 1):199-208.
2004: Kittichai Promrat; Glen Lutchman; Gabriel I Uwaifo; Renee J Freedman; Alejandro Soza; Theo Heller; Edward Doo; Marc G Ghany; Ahalya Premkumar; Yoon Park; TSANYANG LIANG; Jack A Yanovski; David E Kleiner; Jay H Hoofnagle
A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis.
Hepatology (Baltimore, Md.) 2004;39(1):188-96.
2003: Kittichai Promrat; TSANYANG LIANG
Chemokine systems and hepatitis C virus infection: is truth in the genes of the beholders?
Hepatology (Baltimore, Md.) 2003;38(6):1359-62.
2003: David R Milich; TSANYANG LIANG
Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection.
Hepatology (Baltimore, Md.) 2003;38(5):1075-86.
2003: Jay H Hoofnagle; Marc G Ghany; David E Kleiner; Edward Doo; Theo Heller; Kittichai Promrat; Janus Ong; Farooq Khokhar; Alejandro Soza; David Herion; Yoon Park; James E Everhart; TSANYANG LIANG
Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin.
Hepatology (Baltimore, Md.) 2003;38(1):66-74.
2003: Kazumoto Murata; Martin Lechmann; Ming Qiao; Toshiaki Gunji; Harvey Alter; TSANYANG LIANG
Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(11):6753-8.
2003: Kittichai Promrat; David H McDermott; Carlos M Gonzalez; David E Kleiner; Deloris Koziol; Matthew Lessie; Maya N Merrell; Alejandro Soza; Theo Heller; Marc G Ghany; Yoon Park; Harvey Alter; Jay H Hoofnagle; Philip M Murphy; TSANYANG LIANG
Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C.
Gastroenterology 2003;124(2):352-60.
2003: Marc G Ghany; David E Kleiner; Harvey Alter; Edward Doo; Farooq Khokar; Kittichai Promrat; David Herion; Yoon Park; TSANYANG LIANG; Jay H Hoofnagle
Progression of fibrosis in chronic hepatitis C.
Gastroenterology 2003;124(1):97-104.
2003: Michael Thomson; Michelina Nascimbeni; Michael B Havert; Marian E Major; Sophia Gonzales; Harvey Alter; Stephen M Feinstone; Krishna K Murthy; Barbara Rehermann; TSANYANG LIANG
The clearance of hepatitis C virus infection in chimpanzees may not necessarily correlate with the appearance of acquired immunity.
Journal of virology 2003;77(2):862-70.
2003: Ming Qiao; Kazumoto Murata; Anthony R Davis; Sook-Hyang Jeong; TSANYANG LIANG
Hepatitis C virus-like particles combined with novel adjuvant systems enhance virus-specific immune responses.
Hepatology (Baltimore, Md.) 2003;37(1):52-9.
2002: Alejandro Soza; James E Everhart; Marc G Ghany; Edward Doo; Theo Heller; Kittichai Promrat; Yoon Park; TSANYANG LIANG; Jay H Hoofnagle
Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis C.
Hepatology (Baltimore, Md.) 2002;36(5):1273-9.
2002: Heiner Wedemeyer; Xiaosong He; Michelina Nascimbeni; Anthony R Davis; Harry B Greenberg; Jay H Hoofnagle; TSANYANG LIANG; Harvey Alter; Barbara Rehermann
Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(6):3447-58.
2002: Miriam Triyatni; Bertrand Saunier; Padma Maruvada; Anthony R Davis; Luca Ulianich; Theo Heller; Arvind Patel; Leonard D Kohn; TSANYANG LIANG
Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry.
Journal of virology 2002;76(18):9335-44.
2002: TSANYANG LIANG; Marc G Ghany
Hepatitis B e Antigen--the dangerous endgame of hepatitis B.
The New England journal of medicine 2002;347(3):208-10.
2002: Miriam Triyatni; John Vergalla; Anthony R Davis; Kenneth G Hadlock; Steven K H Foung; TSANYANG LIANG
Structural features of envelope proteins on hepatitis C virus-like particles as determined by anti-envelope monoclonal antibodies and CD81 binding.
Virology 2002;298(1):124-32.
2002: Eishiro Mizukoshi; Michelina Nascimbeni; Joshua B Blaustein; Kathleen Mihalik; Charles M Rice; TSANYANG LIANG; Stephen M Feinstone; Barbara Rehermann
Molecular and immunological significance of chimpanzee major histocompatibility complex haplotypes for hepatitis C virus immune response and vaccination studies.
Journal of virology 2002;76(12):6093-103.
2002: Rosa Zampino; Aldo Marrone; Grazia Cirillo; Emanuele Miraglia del Giudice; Riccardo Utili; Peter Karayiannis; TSANYANG LIANG; Giuseppe Ruggiero
Sequential analysis of hepatitis B virus core promoter and precore regions in cancer survivor patients with chronic hepatitis B before, during and after interferon treatment.
Journal of viral hepatitis 2002;9(3):183-8.
2002: Johnson Y N Lau; Robert C Tam; TSANYANG LIANG; Zhi Hong
Mechanism of action of ribavirin in the combination treatment of chronic HCV infection.
Hepatology (Baltimore, Md.) 2002;35(5):1002-9.
2001: J Satoi; Kazumoto Murata; Martin Lechmann; E Manickan; Zhensheng Zhang; Heiner Wedemeyer; Barbara Rehermann; TSANYANG LIANG
Genetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteins.
Journal of virology 2001;75(24):12121-7.
2001: Zhensheng Zhang; N Torii; Zongyi Hu; J Jacob; TSANYANG LIANG
X-deficient woodchuck hepatitis virus mutants behave like attenuated viruses and induce protective immunity in vivo.
The Journal of clinical investigation 2001;108(10):1523-31.
2001: Michael Thomson; Michelina Nascimbeni; S Gonzales; Krishna K Murthy; Barbara Rehermann; TSANYANG LIANG
Emergence of a distinct pattern of viral mutations in chimpanzees infected with a homogeneous inoculum of hepatitis C virus.
Gastroenterology 2001;121(5):1226-33.
2001: Won-Ho Kim; Feng Hong; Barbara Jaruga; Z Hu; Saijun Fan; TSANYANG LIANG; Bin Gao
Additive activation of hepatic NF-kappaB by ethanol and hepatitis B protein X (HBX) or HCV core protein: involvement of TNF-alpha receptor 1-independent and -dependent mechanisms.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2001;15(13):2551-3.
2001: Antonella Cerino; Annalisa Meola; Lusignani G Segagni; Milena Furione; S Marciano; Miriam Triyatni; TSANYANG LIANG; Alfredo Nicosia; Mario U Mondelli
Monoclonal antibodies with broad specificity for hepatitis C virus hypervariable region 1 variants can recognize viral particles.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(7):3878-86.
2001: Martin Lechmann; Kazumoto Murata; J Satoi; John Vergalla; Thomas F Baumert; TSANYANG LIANG
Hepatitis C virus-like particles induce virus-specific humoral and cellular immune responses in mice.
Hepatology (Baltimore, Md.) 2001;34(2):417-23.
2001: E Manickan; J Satoi; T C Wang; TSANYANG LIANG
Conditional liver-specific expression of simian virus 40 T antigen leads to regulatable development of hepatic neoplasm in transgenic mice.
The Journal of biological chemistry 2001;276(17):13989-94.
2001: Edward Doo; TSANYANG LIANG
Molecular anatomy and pathophysiologic implications of drug resistance in hepatitis B virus infection.
Gastroenterology 2001;120(4):1000-8.
2000: TSANYANG LIANG
Odysseus's lament: death of mentor.
Gastroenterology 2000;119(6):1429.
2000: Daryl T-Y Lau; M F Khokhar; Edward Doo; Marc G Ghany; David Herion; Yoon Park; David E Kleiner; P Schmid; Lynn Condreay; Josée Gauthier; M C Kuhns; TSANYANG LIANG; Jay H Hoofnagle
Long-term therapy of chronic hepatitis B with lamivudine.
Hepatology (Baltimore, Md.) 2000;32(4 Pt 1):828-34.
2000: Thomas F Baumert; S Wellnitz; S Aono; J Satoi; David Herion; J Tilman Gerlach; Gerd R Pape; J Y Lau; Jay H Hoofnagle; Hubert E Blum; TSANYANG LIANG
Antibodies against hepatitis C virus-like particles and viral clearance in acute and chronic hepatitis C.
Hepatology (Baltimore, Md.) 2000;32(3):610-7.
2000: Z Zhang; N Torii; A Furusaka; N Malayaman; Z Hu; TSANYANG LIANG
Structural and functional characterization of interaction between hepatitis B virus X protein and the proteasome complex.
The Journal of biological chemistry 2000;275(20):15157-65.
2000: TSANYANG LIANG; Barbara Rehermann; Leonard B Seeff; Jay H Hoofnagle
Pathogenesis, natural history, treatment, and prevention of hepatitis C.
Annals of internal medicine 2000;132(4):296-305.
2000: Raphael Schiffmann; Gary J Murray; Douglas Treco; P Daniel; M Sellos-Moura; M Myers; Jane M Quirk; GC Zirzow; M Borowski; K Loveday; T Anderson; F Gillespie; KL Oliver; Neal Jeffries; Edward Doo; TSANYANG LIANG; Constance Kreps; K Gunter; Karen P Frei; Kevin Crutchfield; R F Selden; Roscoe O Brady
Infusion of alpha-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(1):365-70.
2000: Lev G Nemchinov; TSANYANG LIANG; M M Rifaat; H M Mazyad; Ahmed Hadidi; JM Keith
Development of a plant-derived subunit vaccine candidate against hepatitis C virus.
Archives of virology 2000;145(12):2557-73.
2000: Martin Lechmann; TSANYANG LIANG
Vaccine development for hepatitis C.
Seminars in liver disease 2000;20(2):211-26.
1999: Thomas F Baumert; John Vergalla; J Satoi; Michael Thomson; Martin Lechmann; David Herion; Harry B Greenberg; S Ito; TSANYANG LIANG
Hepatitis C virus-like particles synthesized in insect cells as a potential vaccine candidate.
Gastroenterology 1999;117(6):1397-407.
1999: TSANYANG LIANG
Complementary and alternative medicine: the roots of healing.
Gastroenterology 1999;117(5):1041.
1999: Zongyi Hu; Zhensheng Zhang; Edward Doo; O Coux; Alfred L Goldberg; TSANYANG LIANG
Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex.
Journal of virology 1999;73(9):7231-40.
1999: Santiago J Muñoz; Harvey Alter; Y Nakatsuji; James Shih; R K Reddy; Lennox Jeffers; Eugene R Schiff; AE Reid; A Marrone; Kenneth D Rothstein; Cosme Manzarbeitia; TSANYANG LIANG
The significance of hepatitis G virus in serum of patients with sporadic fulminant and subfulminant hepatitis of unknown etiology.
Blood 1999;94(4):1460-4.
1999: AE Reid; Margaret James Koziel; I Aiza; Lennox Jeffers; R Reddy; Eugene R Schiff; J Y Lau; Jules L Dienstag; TSANYANG LIANG
Hepatitis C virus genotypes and viremia and hepatocellular carcinoma in the United States.
The American journal of gastroenterology 1999;94(6):1619-26.
1998: TSANYANG LIANG
Combination therapy for hepatitis C infection.
The New England journal of medicine 1998;339(21):1549-50.
1998: Thomas F Baumert; A Marrone; John Vergalla; TSANYANG LIANG
Naturally occurring mutations define a novel function of the hepatitis B virus core promoter in core protein expression.
Journal of virology 1998;72(8):6785-95.
1998: Thomas F Baumert; S Ito; D T Wong; TSANYANG LIANG
Hepatitis C virus structural proteins assemble into viruslike particles in insect cells.
Journal of virology 1998;72(5):3827-36.
1997: TSANYANG LIANG
Organizing the future of patient-oriented research?
Gastroenterology 1997;113(4):1061.
1997: V Agnello; TSANYANG LIANG
Is hepatitis C virus a sialodacryoadenitis virus?
Hepatology (Baltimore, Md.) 1997;26(2):509-10.
1997: Margaret James Koziel; TSANYANG LIANG
DNA vaccines and viral hepatitis: are we going around in circles?
Gastroenterology 1997;112(4):1410-4.
1997: T Kawamura; A Furusaka; Margaret James Koziel; Raymond T Chung; T C Wang; Emmett V Schmidt; TSANYANG LIANG
Transgenic expression of hepatitis C virus structural proteins in the mouse.
Hepatology (Baltimore, Md.) 1997;25(4):1014-21.
1996: Thomas F Baumert; S A Rogers; K Hasegawa; TSANYANG LIANG
Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication.
The Journal of clinical investigation 1996;98(10):2268-76.
1996: J Huang; J Kwong; E C Sun; TSANYANG LIANG
Proteasome complex as a potential cellular target of hepatitis B virus X protein.
Journal of virology 1996;70(8):5582-91.
1996: TSANYANG LIANG; AE Reid; R Xavier; Robert Cardiff; Timothy C Wang
Transgenic expression of tpr-met oncogene leads to development of mammary hyperplasia and tumors.
The Journal of clinical investigation 1996;97(12):2872-7.
1996: Thomas F Baumert; TSANYANG LIANG
Precore mutants revisited.
Hepatology (Baltimore, Md.) 1996;23(1):184-6.
1995: R Ni; Y Tomita; F Tokunaga; TSANYANG LIANG; C Noda; A Ichihara; K Tanaka
Molecular cloning of two types of cDNA encoding subunit RC6-I of rat proteasomes.
Biochimica et biophysica acta 1995;1264(1):45-52.
1995: TSANYANG LIANG
p53 proteins and aflatoxin b1: the good, the bad, and the ugly.
Hepatology (Baltimore, Md.) 1995;22(4 Pt 1):1330-2.
1995: Herbert L Bonkovsky; TSANYANG LIANG; K Hasegawa; B Banner
Chronic leukocytoclastic vasculitis complicating HBV infection. Possible role of mutant forms of HBV in pathogenesis and persistence of disease.
Journal of clinical gastroenterology 1995;21(1):42-7.
1995: AE Reid; TSANYANG LIANG
Association of hepatitis C virus and hepatocellular carcinoma in the United States.
Princess Takamatsu symposia 1995;25():41-9.
1994: AE Reid; TSANYANG LIANG
Tumor marker for metastasis: searching for an abnormal needle in a haystack.
Hepatology (Baltimore, Md.) 1994;20(6):1631-4.
1994: Margaret James Koziel; TSANYANG LIANG
Vaccination against hepatitis C virus infection: miles to go before we sleep.
Hepatology (Baltimore, Md.) 1994;20(3):758-60.
1994: K Hasegawa; J Huang; S A Rogers; H E Blum; TSANYANG LIANG
Enhanced replication of a hepatitis B virus mutant associated with an epidemic of fulminant hepatitis.
Journal of virology 1994;68(3):1651-9.
1994: TSANYANG LIANG; Henry Jr. Bodenheimer; R Yankee; N V Brown; K Chang; J Huang; Jack R Wands
Presence of hepatitis B and C viral genomes in US blood donors as detected by polymerase chain reaction amplification.
Journal of medical virology 1994;42(2):151-7.
1994: TSANYANG LIANG; K Hasegawa; S J Munoz; C N Shapiro; B Yoffe; B J McMahon; C Feng; H Bei; M J Alter; Jules L Dienstag
Hepatitis B virus precore mutation and fulminant hepatitis in the United States. A polymerase chain reaction-based assay for the detection of specific mutation.
The Journal of clinical investigation 1994;93(2):550-5.
1994: AE Reid; TSANYANG LIANG
The search for the ultimate screening test for hepatocellular carcinoma continues.
Hepatology (Baltimore, Md.) 1994;19(1):255-7.
1993: J Huang; TSANYANG LIANG
A novel hepatitis B virus (HBV) genetic element with Rev response element-like properties that is essential for expression of HBV gene products.
Molecular and cellular biology 1993;13(12):7476-86.
1993: TSANYANG LIANG; Lennox Jeffers; K R Reddy; M de Medina; I T Parker; Hugo Cheinquer; V Idrovo; A Rabassa; Eugene R Schiff
Viral pathogenesis of hepatocellular carcinoma in the United States.
Hepatology (Baltimore, Md.) 1993;18(6):1326-33.
1993: TSANYANG LIANG; V Rustgi; E Galun; H E Blum
HCV RNA in patients with chronic hepatitis C treated with interferon-alpha.
Journal of medical virology 1993;40(1):69-75.
1993: TSANYANG LIANG; W J Makdisi; S Sun; K Hasegawa; Y Zhang; J R Wands; C H Wu; G Y Wu
Targeted transfection and expression of hepatitis B viral DNA in human hepatoma cells.
The Journal of clinical investigation 1993;91(3):1241-6.
1993: TSANYANG LIANG; Lennox Jeffers; R K Reddy; M O Silva; Hugo Cheinquer; A Findor; M de Medina; P O Yarbough; G R Reyes; Eugene R Schiff
Fulminant or subfulminant non-A, non-B viral hepatitis: the role of hepatitis C and E viruses.
Gastroenterology 1993;104(2):556-62.
1992: Jack R Wands; TSANYANG LIANG; Hubert E Blum; David A Shafritz
Molecular pathogenesis of liver disease during persistent hepatitis B virus infection.
Seminars in liver disease 1992;12(3):252-64.
1992: Hubert E Blum; Z S Zhang; E Galun; Fritz von Weizsäcker; B Garner; TSANYANG LIANG; Jack R Wands
Hepatitis B virus X protein is not central to the viral life cycle in vitro.
Journal of virology 1992;66(2):1223-7.
1991: K Hasegawa; J K Huang; Jack R Wands; H Obata; TSANYANG LIANG
Association of hepatitis B viral precore mutations with fulminant hepatitis B in Japan.
Virology 1991;185(1):460-3.
1991: Hubert E Blum; TSANYANG LIANG; E Galun; Jack R Wands
Persistence of hepatitis B viral DNA after serological recovery from hepatitis B virus infection.
Hepatology (Baltimore, Md.) 1991;14(1):56-63.
1991: TSANYANG LIANG; K Hasegawa; Nurit Rimon; Jack R Wands; E Ben-Porath
A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis.
The New England journal of medicine 1991;324(24):1705-9.
1991: TSANYANG LIANG; Yaacov Baruch; E Ben-Porath; R Enat; Lucyna Bassan; N V Brown; Nurit Rimon; Hubert E Blum; Jack R Wands
Hepatitis B virus infection in patients with idiopathic liver disease.
Hepatology (Baltimore, Md.) 1991;13(6):1044-51.
1991: Hubert E Blum; E Galun; TSANYANG LIANG; Fritz von Weizsäcker; Jack R Wands
Naturally occurring missense mutation in the polymerase gene terminating hepatitis B virus replication.
Journal of virology 1991;65(4):1836-42.
1990: TSANYANG LIANG; Hubert E Blum; Jack R Wands
Characterization and biological properties of a hepatitis B virus isolated from a patient without hepatitis B virus serologic markers.
Hepatology (Baltimore, Md.) 1990;12(2):204-12.
1990: B Bressac; K M Galvin; TSANYANG LIANG; Kurt J Isselbacher; Jack R Wands; Mehmet Ozturk
Abnormal structure and expression of p53 gene in human hepatocellular carcinoma.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(5):1973-7.
1989: TSANYANG LIANG; K J Isselbacher; Jack R Wands
Rapid identification of low level hepatitis B-related viral genome in serum.
The Journal of clinical investigation 1989;84(4):1367-71.
1986: G Grieninger; TSANYANG LIANG; G Beuving; V Goldfarb; S A Metcalfe; U Muller-Eberhard
Hemopexin is a developmentally regulated, acute-phase plasma protein in the chicken.
The Journal of biological chemistry 1986;261(33):15719-24.
1984: TSANYANG LIANG; G G Carmichael; T L Benjamin
A polyoma mutant that encodes small T antigen but not middle T antigen demonstrates uncoupling of cell surface and cytoskeletal changes associated with cell transformation.
Molecular and cellular biology 1984;4(12):2774-83.
1984: G Carmichael; Brian Schaffhausen; Gail Mandel; TSANYANG LIANG; T L Benjamin
Transformation by polyoma virus is drastically reduced by substitution of phenylalanine for tyrosine at residue 315 of middle-sized tumor antigen.
Proceedings of the National Academy of Sciences of the United States of America 1984;81(3):679-83.
1983: G Grieninger; P W Plant; TSANYANG LIANG; R G Kalb; D Amrani; M W Mosesson; KM Hertzberg; J Pindyck
Hormonal regulation of fibrinogen synthesis in cultured hepatocytes.
Annals of the New York Academy of Sciences 1983;408():469-89.
1981: TSANYANG LIANG; G Grieninger
Direct effect of insulin on the synthesis of specific plasma proteins: biphasic response of hepatocytes cultured in serum- and hormone-free medium.
Proceedings of the National Academy of Sciences of the United States of America 1981;78(11):6972-6.
1981: P W Plant; TSANYANG LIANG; J Pindyck; G Grieninger
Serum stimulation of plasma protein synthesis in culture is selective and rapidly reversible.
Biochimica et biophysica acta 1981;655(3):407-12.